# Serum Institute acquires Czech arm of Nanotherapeutics for €72 million

Serum Institute of India acquired the Czech arm of US-based Nanotherapeutics for 72 million euros (around Rs 500 crore). The acquisition will quadruple its injectable polio dosage capacity to 200 million doses a year by 2019.

- Type: Acquisition
- Announced: 2017-04-25
- Where: Czechia
- Value: $78.0M (72.0M EUR)
- Status: completed
- Capacity: 200 million injectable polio doses per year (by 2019)
- Products: injectable polio vaccine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Serum Institute of India](https://endata.com/companies/23795.md) (acquirer)
- [Nanotherapeutics](https://endata.com/companies/23796.md) (target)

## Sources

- [business-standard.com](https://www.business-standard.com/article/companies/serum-institute-acquires-czech-firm-to-expand-polio-vaccine-capabilities-117042500969_1.html), 2017-04-25: "This acquisition complements our facility in Netherlands which we acquired five years ago and will increase our injectable polio vaccine capability four times to 200 million doses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
